Free Trial

Curaleaf (OTCMKTS:CURLF) Trading Up 10.9% - Time to Buy?

Curaleaf logo with Medical background

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report)'s share price was up 10.9% during trading on Tuesday . The stock traded as high as $0.95 and last traded at $0.92. Approximately 577,178 shares changed hands during mid-day trading, a decline of 5% from the average daily volume of 604,824 shares. The stock had previously closed at $0.83.

Curaleaf Stock Up 3.1%

The company has a debt-to-equity ratio of 1.08, a quick ratio of 0.70 and a current ratio of 1.41. The company has a market capitalization of $663.38 million, a price-to-earnings ratio of -3.23 and a beta of 0.62. The business's 50 day moving average is $0.86 and its 200 day moving average is $1.08.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported ($0.07) EPS for the quarter, meeting analysts' consensus estimates of ($0.07). Curaleaf had a negative return on equity of 14.12% and a negative net margin of 17.37%. Sell-side analysts anticipate that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current year.

About Curaleaf

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Read More

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines